(Total Views: 525)
Posted On: 03/14/2021 7:42:59 PM
Post# of 145871
![Avatar](https://investorshangout.com/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
Re: nothingspecial #82984
“So are you suggesting that this is not an extension of cd12 & more of a stand alone trial?”
Good questions. I was under the assumption that the 140 patient protocol is a standalone trial, hence the “CD16” identifier. I don’t think an extension of CD12 would get its own identifier, but I could be wrong.
Good questions. I was under the assumption that the 140 patient protocol is a standalone trial, hence the “CD16” identifier. I don’t think an extension of CD12 would get its own identifier, but I could be wrong.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)